This article covers TrialView, a London-based legal technology firm, which has raised £3m in growth funding led by Elkstone Ventures. The capital will support acceleration of its AI-driven litigation platform, hiring and planned expansion into the US, Singapore and Australia to serve law firms, judges and arbitrators.
TrialView, a London-based legal technology company, has raised £3 million (around $4.1 million) in a growth round led by Elkstone Ventures. The funding will support further development of its AI-driven litigation platform and finance hires as the business pushes into new markets, including the US, Singapore and Australia.
TrialView’s software is already used by a substantial portion of the UK legal market, including 15 of the top 20 law firms, and has been deployed in high-value disputes such as the Russian Aviation litigation, which involves claims in excess of £4.6 billion. The company reports nearly £2.3 million in annual recurring revenue over the past three years and says it has been profitable to date, a relatively uncommon position for a scaling tech company.
For legal teams and courts, tools that speed document review, evidence presentation and case preparation can materially reduce time and cost in complex litigation. That practical use case, demonstrated in London’s Commercial Court and other large matters, helps explain investor interest in specialist legaltech.
TrialView describes its platform as an AI-powered litigation environment that mines documents, streamlines workflows and surfaces evidence to support case preparation and trial presentation. The company says the software is used by law firms, judges and arbitrators, and that it was developed by trial lawyers and practitioners to meet the needs of disputes teams.
The product positioning is focused on supporting the lifecycle of a case, from early preparation through to courtroom presentation, rather than on narrow point solutions such as e-discovery alone.
The £3 million round was led by Elkstone Ventures. TrialView had been primarily self-funded until now and intends to use the new capital to accelerate AI feature development and to increase headcount across development, sales and customer success as it expands internationally.
In the announcement, Niall McEvoy, Managing Director of Venture at Elkstone, said:
"TrialView has developed a truly transformational platform for the legal sector. Their team has a deep understanding of their customers and the challenges they face, borne of their own legal background, built for practitioners by practitioners. With a stellar customer base of top legal firms already using the platform, we are confident that TrialView's software will become an indispensable tool for law firms globally, helping them to maximize their efficiency, enhance their legal strategy and increase their success rate."
The investor stated the decision reflects TrialView’s customer traction and practitioner-led product design, citing the company’s existing client base among top law firms as a key factor in the investment decision.
If you're researching potential backers in this space:
TrialView’s founder and chief executive, Stephen Dowling, said the investment marked a milestone for the company and would support market expansion and product development.
In the announcement, Stephen Dowling, Founder and CEO of TrialView and Senior Counsel, said:
"This investment is a significant milestone for TrialView. It helps us promote our vision of helping litigators serve their clients through more effective case preparation. Our platform is more than an AI tool - it’s a partner for disputes teams through the life cycle of a case. We are thrilled to partner with Elkstone Ventures, who share our commitment to innovation and growth. This funding will allow us to accelerate the development of our AI-driven features, expand our team, and establish a stronger presence in key markets, including the US.”
The round illustrates two broader trends in UK legaltech and enterprise software. First, specialist legal technology that solves for courtroom workflow and evidence presentation is gaining traction with large firms handling high-value disputes. Second, TrialView’s route — growing by self-funding to profitability before taking institutional backing — contrasts with the more common capital‑intensive, growth-at-all-costs model seen across European startups.
As TrialView targets North America and Asia, the funding also reflects continued investor appetite for UK-founded B2B software that can scale internationally from a strong domestic customer base.
Click here for a full list of 7,526+ startup investors in the UK